Literature DB >> 31249095

Low-risk bowel cancer symptoms: is it time for FIT?

Mazlan Kamarudin1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31249095      PMCID： PMC6592344          DOI： 10.3399/bjgp19X704501

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  6 in total

1.  Use of faecal occult blood tests in symptomatic patients.

Authors:  Robert Steele; Ian Forgacs; Gwyn McCreanor; Sally Benton; Michael Machesney; Colin Rees; Stephen P Halloran; Muti Abulafi; Deborah Alsina
Journal:  BMJ       Date:  2015-08-11

2.  A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer.

Authors:  A Gillberg; E Ericsson; F Granstrom; L I Olsson
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

3.  Miss rate of lung cancer on the chest radiograph in clinical practice.

Authors:  L G Quekel; A G Kessels; R Goei; J M van Engelshoven
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

Review 4.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Gastroenterology       Date:  2016-10-19       Impact factor: 22.682

Review 5.  Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis.

Authors:  Patrick F van Rheenen; Els Van de Vijver; Vaclav Fidler
Journal:  BMJ       Date:  2010-07-15

Review 6.  Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.

Authors:  Marie Westwood; Shona Lang; Nigel Armstrong; Sietze van Turenhout; Joaquín Cubiella; Lisa Stirk; Isaac Corro Ramos; Marianne Luyendijk; Remziye Zaim; Jos Kleijnen; Callum G Fraser
Journal:  BMC Med       Date:  2017-10-24       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.